More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, optic nerves, and spine. MS is an unpredictable disorder, with symptoms—such as ...
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple sclerosis ...
The progression of relapsing-onset multiple sclerosis (MS) and its associated disability may be slowing, results from a large population-based study suggest. In an evaluation of more than 7000 ...
Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS). The research combined PET imaging data from 114 Finnish MS ...
Feb. 25 (UPI) --A diet rich in fish may help slow down the progression of the incurable, often disabling autoimmune disease of multiple sclerosis, according to new, long-term Swedish study published ...
Multiple sclerosis is a chronic immune-mediated disorder characterised by focal inflammatory demyelination and diffuse neurodegeneration within the central nervous system. Disease trajectories range ...
Women with relapsing-remitting multiple sclerosis (MS), particularly after menopause, experienced a higher risk of relapse-independent worsening, whereas men showed a greater worsening of disability ...
– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in ...
Changes in the upper spinal cord, measured on routine brain MRI, may help flag higher MS progression risk in people with RRMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results